LTL
| Topic | Replies | Views | Activity | |
|---|---|---|---|---|
| US FDA on LTL adjustments for Nitrosamines |
|
20 | 952 | October 8, 2026 |
| Mutagenic and carcinogenic potency determinations for NDMA support the cumulative dose assumption underpinning the less-than-lifetime Threshold of Toxicological Concern -Pub |
|
0 | 187 | April 21, 2026 |